Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01657916 · ClinicalTrials.gov registry record
5-Year Objective and Subjective Results of a Mid-Urethral Sling
A clinical trial, sponsored by Atlantic Health System.
- Completed
- Registry status
- 90
- Enrollment target
NCT01657916: Completed study, sponsored by Atlantic Health System.
NCT01657916 is a clinical trial that has completed, run by Atlantic Health System. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01657916 has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
Evaluate 5-year objective and subjective cure rates after implant of the retropubic Align Urethral Support System.
Primary Outcome
Patient will void and their post-void residual amount of urine will be obtained by a catheter. That same catheter will be left in place and used to fill the bladder with 250ml sterile saline. The patient will then be asked to vigorously cough in the upright sitting and standing positions. A positive "cough test" will be defined as any leakage of urine that is visualized during coughing in the sitting or standing position.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-07 |
What the finished NCT01657916 record still lists
NCT01657916 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01657916 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01657916 about?
NCT01657916 is a clinical study titled "5-Year Objective and Subjective Results of a Mid-Urethral Sling". Evaluate 5-year objective and subjective cure rates after implant of the retropubic Align Urethral Support System.
What is the current status of trial NCT01657916?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2012-06. Estimated completion is 2015-07.
Who is sponsoring clinical trial NCT01657916?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia